Back to Rare Disease
NCT01880983
NCT01880983
Who may be able to join
Who might be able to join this trial:
- You must already be enrolled in a separate study called the Longitudinal Study of the Porphyrias and have a diagnosis of EPP (Erythropoietic Protoporphyria).
- You, or your parent or guardian if you are a child, must be able to read and sign a consent form agreeing to take part in the study.
Who may not be able to join:
- You are not currently enrolled in the Longitudinal Study of the Porphyrias.
- You are under 7 years of age.
- You have a cognitive impairment that affects your ability to participate (confirm with trial site).
- You are unwilling to have a blood sample taken, which would be used to create a special type of cell line for research purposes.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
University of Alabama at Birmingham
Registry
clinicaltrials_gov
Start date
1 November 2011
Est. completion
31 December 2020
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Mitoferrin-1 expression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.